67 kDa laminin receptor: Structure, function and role in cancer and infection;Il recettore per la laminina di 67 kDa: Struttura, funzione e ruolo nel cancro e nell'infezione

Infezioni in Medicina

Volumn 20, Issue SUPPL. 2, 2012, Pages 8-12

  Rea, Vincenza Elena Anna ^a   Rossi, Francesca W ^b   de Paulis, Amato ^b   Ragno, Pia ^c   Selleri, Carmine ^d   Montuori, Nunzia ^a  

^a Department of Cellular and Molecular Biology and Pathology   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

^d UNIVERSITY OF SALERNO   (Italy)

Author keywords

67 laminin receptor; Extracellular matrix; Prion protein

Indexed keywords

LAMININ; LAMININ RECEPTOR; PRION PROTEIN; VIRUS RECEPTOR;

BACTERIAL INFECTION; CELL NUCLEUS; DENGUE VIRUS; EXTRACELLULAR MATRIX; HUMAN; INTERNALIZATION; METASTASIS POTENTIAL; NEOPLASM; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SINDBIS VIRUS; VIRUS INFECTION;

ANIMALS; HUMANS; INFECTION; NEOPLASMS; PRIONS; RECEPTORS, LAMININ; RIBOSOMAL PROTEINS;

EID: 84867523350     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Montuori N., Sobel M.E. The 67-kDa laminin receptor and tumor progression. Curr. Top. Microbiol. Immunol. 213, 205-214, 1996.
2. Rao C.N., Castronovo V., Schmitt M.C., et al. Evidence for a precursor of the high-affinity metastasisassociated murine laminin receptor. Biochemistry 28, 7476-7486, 1989.
3. Landowski T.H., Dratz E.A., Starkey J.R. Studies of the structure of the metastasis-associated 67 kDa laminin binding protein: fatty acid acylation and evidence supporting dimerization of the 32 kDa gene product to form the mature protein. Biochemistry 34, 11276-11287, 1995.
4. Ardini E., Tagliabue E., Magnifico A., et al. Coregulation and physical association of the 67 kD monomeric laminin receptor and the 64 integrin. J Biol. Chem. 272, 2342-2345, 1997.
5. Berno V., Porrini D., Castiglioni F., et al. The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1. Endocr. Relat. Cancer 12, 393-406, 2005.
6. Ardini E., Sporchia B., Pollegioni L., et al. Identification of a novel function for 67-kDa laminin receptor: increase in laminin degradation rate and release of motility fragments. Cancer Res. 62, 1321-1325, 2002.
7. Rieger R., Edenhofer F., Lasmézas C.I., Weiss S. The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nat. Med. 3, 1383-1388, 1997.
8. Gauczynski S., Peyrin J.M., Haïk S., et al. The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J. 20, 5863-5875, 2001.
9. Patarroyo, M., Tryggvascon, K., Virtanen, I. Laminin isoforms in tumour invasion, angiogenesis and metastasis. Semin. Cancer Biol. 12, 197-207, 2002.
10. Kazmin D.A., Hoyt T.R., Taubner L., et al. Phage display mapping for peptide 11 sensitive sequences binding to laminin-1. J. Mol. Biol. 298, 431-45, 2000.
11. Leucht C., Simoneau S., Rey C., Vana K., Rieger R., Lasmézas C.I., Weiss S. The 37kDa/67 kDa laminin receptor is required for PrP(Sc) propagation in scrapie-infected neuronal cells. EMBO Rep. 4, 290-295, 2003.
12. Hundt C., Peyrin J.M., Haïk S., et al. Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor. EMBO J. 20, 5876-5886, 2001.
13. Menard S., Tagliabue E., Colnaghi M.I. The 67 kDa laminin receptor as a prognostic factor in human cancer. Breast Cancer Res. Treat. 52, 137-145, 1998.
14. Montuori N., Selleri C., Risitano A.M., et al. Expression of the 67-kDa Laminin Receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation. Clin. Cancer Res. 5, 1465-1472, 1999.
15. Montuori N., Müller F., De Riu S., et al. Laminin receptors in differentiated thyroid tumors: restricted expression of the 67-kilodalton laminin receptor in follicular carcinoma cells. J. Clin. Endocrinol. Metab. 84, 2086-2092, 1999.
16. Stitt A.W., McKenna D., Simpson D.A.C., et al. The 67 kDa laminin receptor is preferentially expressed by proliferating retinal vessels in a murine model of ischemic retinopathy. Am. J. Pathol. 152, 1359-1365, 1998.
17. Selleri C., Ragno P., Ricci P., et al. The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization. Blood. 108, 2476-2484, 2006.
18. Scheiman J., Tseng J.C., Zheng Y., Meruelo D. Multiple functions of the 37/67-kd laminin receptor make it a suitable target for novel cancer gene therapy. Mol. Ther. 18, 63-74, 2010.
19. Formisano P., Ragno P., Pesapane A., et al. PED/PEA-15 interacts with the 67 kDa laminin receptor and regulates cell adhesion, migration, proliferation and apoptosis. J. Cell. Mol. Med. 16: 1435-1446, 2012.
20. Vana K., Zuber C., Pflanz H., et al. LRP/LR as an alternative promising target in therapy of prion diseases, Alzheimer's disease and cancer. Infect. Disord. Drug Targets. 9, 69-80, 2009.
21. Kim K.J., Chung J.W., Kim K. S. 67-kDa laminin receptor promotes internalisation of cytotoxic necrotizing factor 1-expressing E. coli K1 into human brain microvascular endothelial cells. J. Biol. Chem. 280, 1360-1368, 2005.
22. Nelson J., McFerran N.V., Pivato G., et al. The 67 kDa laminin receptor: structure, function and role in disease. Biosci. Rep., 28, 33-48, 2008.
23. Baloui H., von Boxberg Y., Vinh J., et al. Cellular prion protein/laminin receptor: distribution in adult central nervous system and characterization of an isoform associated with a subtype of cortical neurons. Eur. J. Neurosci. 20, 2605-2616, 2004.
24. Pflanz H., Vana K., Mitteregger G., et al. Microinjection of lentiviral vectors expressing small interfering RNAs directed against laminin receptor precursor mRNA prolongs the pre-clinical phase in scrapie-infected mice. J. Gen. Virol. 90, 269-274, 2009.
25. Kolodziejczak D., Da Costa Dias B., Zuber C., et al. Prion interaction with the 37-kDa/67-kDa laminin receptor on enterocytes as a cellular model for intestinal uptake of prions. J. Mol. Biol. 402, 293-300, 2010.
26. Omar A., Jovanovic K., Da Costa Dias B., et al. Patented biological approaches for the therapeutic modulation of the 37 kDa/67 kDa laminin receptor. Expert Opin. Ther. Pat. 21, 35-53, 2011.
27. Lavecchia A., Di Giovanni C., Pesapane A., et al. Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening. J Med Chem. 55, 4142-4158, 2012.